D. Medical Industries

Brain Scientific Signs Agreement with MVAP Medical Supplies to Go After Rapidly Growing Pediatric Neurodiagnostic Space

Retrieved on: 
Thursday, December 15, 2022
Pediatrics, IOM, Neurology, D. Medical Industries, D, Failure, Government, FDA, Brain, Rafael L. Bras, EMG, OEM, Intensive care unit, Sleep, Public expenditure, Projection, EEG, OTCQB, Research, Child, Patient, Medical device, Medical imaging, Fulcrum

LAKEWOOD RANCH, Fla., Dec. 15, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific ( OTCQB:BRSF ), a Florida-based applied science technology company, announces today a new distribution agreement with MVAP Medical Supplies to drive sales into the rapidly growing and underserved pediatric EEG marketplace.

Key Points: 
  • LAKEWOOD RANCH, Fla., Dec. 15, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific ( OTCQB:BRSF ), a Florida-based applied science technology company, announces today a new distribution agreement with MVAP Medical Supplies to drive sales into the rapidly growing and underserved pediatric EEG marketplace.
  • “For pediatric EEGs, Brain Scientific’s innovative NeuroCapTM – which shortens EEG setup times and provides staff and patients with more ease of use and comfort – is a perfect fit,” said Eric Jensen, CEO of MVAP Medical Supplies.
  • It has critical applications in pediatrics, emergency and ICUs, at-home care and research,” said Hassan Kotob, CEO of Brain Scientific.
  • Brain Scientific is committed to developing next-gen solutions that advance the future of medical and OEM devices.

Brain Scientific Announces Release of Improved NeuroCap(TM) and New US Distribution Deal with D&D Medical

Retrieved on: 
Tuesday, November 15, 2022
D, D. Medical Industries, Epilepsy, Environment, Electrode, Diagnosis, Stroke, PET, Ambulance, Hospital, Projection, Partnership, Patient, Neurology, Government, Federal Food, Drug, and Cosmetic Act, EEG, OEM, Failure, OTCQB, Public expenditure, FDA, Medical device, Medical imaging

D&D Medical, Inc., brings innovative medical technologies to market by educating medical professionals in their use and distributing them to where they are needed most.

Key Points: 
  • D&D Medical, Inc., brings innovative medical technologies to market by educating medical professionals in their use and distributing them to where they are needed most.
  • Brain Scientifics newly improved NeuroCap recently entered production for the company and its distributors to build stock and fulfill customer requests.
  • Our improved NeuroCap is a more comfortable, easy-to-use, and efficient way to conduct EEG exams, said Hassan Kotob, chairman and CEO of Brain Scientific.
  • Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices.

Smart Meter Remote Patient Monitoring Devices Powered by AT&T IoT Connectivity to be Featured at HIMSS

Retrieved on: 
Thursday, March 10, 2022
Industry, AT, Physician, VP, Blood pressure, D. Medical Industries, Telehealth, Metre, HIMSS, CCM, Smart meter, News, Patient, Population health, Hypertension, Chronic care management, Stroke, Solution, COO, Population, Wi-Fi, RPM, CEO, AT&T, Internet, Mobile phone, Pharmaceutical industry, Medical device

Smart Meter, a leader in cellular-enabled remote patient monitoring (RPM) devices and serviceswill unveil its new iBloodPressure 2.0 developed jointly with A&D Medical at HIMSS March 14 to 18, 2022 in Orlando.

Key Points: 
  • Smart Meter, a leader in cellular-enabled remote patient monitoring (RPM) devices and serviceswill unveil its new iBloodPressure 2.0 developed jointly with A&D Medical at HIMSS March 14 to 18, 2022 in Orlando.
  • All Smart Meter devices transmit data upon the first use without the need for training, syncing, apps, Wi-Fi, internet, or smartphones.
  • "Our collaboration with Smart Meter is another example of how AT&T IoT connectivity is advancing connected healthcare."
  • Smart Meter's remote patient monitoring solutions are recognized as the standard for the remote patient monitoring industry and are regarded for their high patient retention and satisfaction.

Cold Plasma Market 2022-2026: Geographic Growth Opportunities - Market in China to Showcase the Highest Growth During the Forecast Period - ResearchAndMarkets.com

Retrieved on: 
Friday, February 11, 2022
Medical Supplies, Health, Wound healing, Plastic, Electronics, Polymer, Meat, Food, Textile, D. Medical Industries, Food safety, Textile industry, Medicine, Poultry, Fluorine, Oil, Decontamination, R, International Union of Food, Agricultural, Hotel, Restaurant, Catering, Tobacco and Allied Workers' Associations, Competition, USD, Market, Growth, Atmosphere, Adhesion, COVID-19, CAGR, Adhesive, Pet, Fine chemical, Lithium, Printing, Application, Industry

The global cold plasma market size is expected to reach USD 3.3 billion by 2026 from USD 1.6 billion in 2021, at a CAGR of 15.0% during the forecast period.

Key Points: 
  • The global cold plasma market size is expected to reach USD 3.3 billion by 2026 from USD 1.6 billion in 2021, at a CAGR of 15.0% during the forecast period.
  • The growth in this market is primarily attributed to the benefits of cold plasma, such as its environment-friendliness, increasing use of cold plasma in wound healing and cancer treatment, innovations in textile production, growing food safety concerns, innovations in cold plasma technology, and the increasing use of cold plasma in meat and poultry packaging decontamination.
  • Based on the regime for the polymer & plastic industry, the cold plasma market has been segmented into atmospheric cold plasma and low-pressure cold plasma.
  • Europe is expected to account for the largest share of the global cold plasma market in 2026.

Smart Meter Announces Partnership With A&D Medical

Retrieved on: 
Tuesday, December 21, 2021
Caregiver, CCM, D. Medical Industries, Technology, Patient, Adoption, COO, Blood pressure, CEO, Partnership, Metre, Smart meter, Industry, A&D, RPM, Wi-Fi, Health, Telehealth, Solution, Population health, A&D Company, Mobile phone, Medical device

TAMPA, Fla., Dec. 21, 2021 /PRNewswire/ -- Smart Meter , the leader in cellular-enabled remote patient monitoring (RPM) data and devices, today announced a partnership with A&D Medical , a global leader in connected health and biometric measurement devices and services.

Key Points: 
  • TAMPA, Fla., Dec. 21, 2021 /PRNewswire/ -- Smart Meter , the leader in cellular-enabled remote patient monitoring (RPM) data and devices, today announced a partnership with A&D Medical , a global leader in connected health and biometric measurement devices and services.
  • Through this partnership, Smart Meter and A&D Medical will develop and deliver top-quality RPM devices that use advanced cellular-enabled technology to best connect patients, caregivers, and healthcare providers.
  • "We are thrilled to partner with A&D Medical to bring the highest quality devices and data to patients and their providers," said Casey Pittock, CEO, Smart Meter.
  • Smart Meter is the leading supplier of cellular-enabled virtual care technologies including the iGlucose, iBloodPressure, iScale, SmartRPM cloud platform, data, and services.

Worldwide Vinyl Methyl Silicone Industry to 2026 - Key Drivers and Restraints - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 6, 2021
Chemicals, Plastics, Manufacturing, Indian government response to the COVID-19 pandemic, USD, Automotive industry, Ozone, Water, Ageing, COVID-19, D. Medical Industries, Population, Electricity, Oil, Union, Solvent, Government, Methyl group, Urbanization, Growth, Electronics, Awareness, Acid, Automotive industry by country, Membrane, Industry, Thermoplastic

Factors such as the growing demand for Vinyl Methyl Silicone in the Automotive industry attributed to its high wear and tear strength, high flexibility, and high durability have made Vinyl Methyl Silicone a preferred choice in the industry to manufacture automotive components gaskets, seals, tubing, etc.

Key Points: 
  • Factors such as the growing demand for Vinyl Methyl Silicone in the Automotive industry attributed to its high wear and tear strength, high flexibility, and high durability have made Vinyl Methyl Silicone a preferred choice in the industry to manufacture automotive components gaskets, seals, tubing, etc.
  • The demand for Vinyl Methyl Silicone in the medical industry for wound dressing and surgical implants has been on the surge due to its excellent biocompatibility.
  • However, the fluctuations in the prices of raw materials for Vinyl Methyl Silicone manufacturing are expected to hamper Vinyl Methyl Silicone market growth in the forecasted years.
  • The Automotive Industry is a prime consumer of Vinyl Methyl Silicone globally and is expected to drive the future market.

Rosenberger and STMicroelectronics Cooperate to Develop a Unique High-Speed Contactless Connector Based on 60GHz Wireless Technology

Retrieved on: 
Tuesday, October 5, 2021
Temperature, STM, Internet, Solution, Immunity, Vibration, D. Medical Industries, Dust, Electronics, Technology, STMicroelectronics, Rosenberger, RF, Movement, NYSE, Name, Rotation, Television, Printed circuit board

In working with ST, we see limitless application possibilities for our connector, which provides high-reliability and high-throughput at low power.

Key Points: 
  • In working with ST, we see limitless application possibilities for our connector, which provides high-reliability and high-throughput at low power.
  • We developed the ST60A2 contactless transceiver to allow customers to create reliable, high data-rate, extremely power-efficient wireless links.
  • Rosenbergers expertise in interconnects combined with our RF chip is an outstanding example of the value of the technology, added Laurent Malier, RF&Communications Division General Manager, STMicroelectronics.
  • Our technologies enable smarter mobility, more efficient power and energy management, and the wide-scale deployment of the Internet of Things and 5G technology.

Avacta’s Diagnostic Division Achieves ISO 13485 Certification

Retrieved on: 
Wednesday, July 14, 2021
Biotechnology, Medical devices, Health, Pharmaceutical, Oncology, Medical technology, Medical equipment, ISO 13485, Medicine, Technology, Science and technology, Medical device, D. Medical Industries, Quality management

The ISO 13485 standard defines the comprehensive requirements for quality management for a developer and legal manufacturer of diagnostic products and medical devices.

Key Points: 
  • The ISO 13485 standard defines the comprehensive requirements for quality management for a developer and legal manufacturer of diagnostic products and medical devices.
  • ISO 13485 certification means that the CE mark for the AffiDX SARS-CoV-2 antigen lateral flow test can be transferred to Avacta from its partner, Mologic, and Avacta will be legal manufacturer of all future in-vitro diagnostic products.
  • Dr Alastair Smith, Chief Executive Officer of Avacta Group, commented: We are delighted that Avactas diagnostics division has achieved ISO 13485 certification.
  • ISO 13485 certification is recognised globally by our partners, customers and regulatory bodies alike as the medical device industry benchmark for quality.

Global Insulin Pumps Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 26, 2021
Diabetes, Pharmaceutical, Health, Medical devices, Clinical medicine, Medicine, Endocrine system, Peptide hormones, Recombinant proteins, Insulin pump, Insulin, Medical device, D. Medical Industries

The "Insulin Pumps Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Insulin Pumps Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global insulin pumps market exhibited moderate growth during 2015-2020.
  • Looking forward, the publisher expects the global insulin pumps market to reach a value of US$ 5.6 Billion by 2026.
  • Insulin pumps are small computerized medical devices that can be clipped on to a belt, pocket or hidden under the clothes.

CardioComm Solutions Completes Issuance of Shares for Debt

Retrieved on: 
Wednesday, May 12, 2021
Medicine, Branches of biology, Clinical medicine, Cardiac electrophysiology, Electrocardiography, Electrodiagnosis, Electrophysiology, Science and technology in the Netherlands, Debt settlement, ISO 13485, D. Medical Industries, ERT

b'Toronto, Ontario--(Newsfile Corp. - May 12, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it has completed its previously announced issuance of shares for debt (see the Company\'s press releases dated April 27, 2021 and April 8, 2021 for further details).\nUnder debt settlement agreements, the Company has issued an aggregate of 3,353,644 common shares of the Company ("Shares") to directors, employees and consultants of the Company to settle debt for services provided to the Company.

Key Points: 
  • b'Toronto, Ontario--(Newsfile Corp. - May 12, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it has completed its previously announced issuance of shares for debt (see the Company\'s press releases dated April 27, 2021 and April 8, 2021 for further details).\nUnder debt settlement agreements, the Company has issued an aggregate of 3,353,644 common shares of the Company ("Shares") to directors, employees and consultants of the Company to settle debt for services provided to the Company.
  • Products are sold worldwide through a combination of an external distribution network and a North American-based sales team.
  • CardioComm Solutions has earned the ISO 13485 certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).\nFOR FURTHER INFORMATION PLEASE CONTACT:\nThis release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items.
  • Such statements and information reflect management\'s current beliefs and are based on information currently available to management.